- Home
- ALLY vs ICLR Comparison
ALLY vs ICLR Comparison
Compare ALLY & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLY
- ICLR
- Stock Information
- Founded
- ALLY 1919
- ICLR 1990
- Country
- ALLY United States
- ICLR Ireland
- Employees
- ALLY N/A
- ICLR N/A
- Industry
- ALLY Major Banks
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ALLY Finance
- ICLR Health Care
- Exchange
- ALLY Nasdaq
- ICLR Nasdaq
- Market Cap
- ALLY 11.3B
- ICLR 11.4B
- IPO Year
- ALLY 2014
- ICLR 1998
- Fundamental
- Price
- ALLY $36.95
- ICLR $146.48
- Analyst Decision
- ALLY Buy
- ICLR Buy
- Analyst Count
- ALLY 19
- ICLR 12
- Target Price
- ALLY $43.19
- ICLR $204.18
- AVG Volume (30 Days)
- ALLY 4.6M
- ICLR 1.1M
- Earning Date
- ALLY 07-18-2025
- ICLR 07-23-2025
- Dividend Yield
- ALLY 3.24%
- ICLR N/A
- EPS Growth
- ALLY N/A
- ICLR 11.53
- EPS
- ALLY 0.61
- ICLR 9.19
- Revenue
- ALLY $6,658,000,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- ALLY $20.15
- ICLR N/A
- Revenue Next Year
- ALLY $14.71
- ICLR $2.10
- P/E Ratio
- ALLY $60.50
- ICLR $15.62
- Revenue Growth
- ALLY N/A
- ICLR N/A
- 52 Week Low
- ALLY $29.52
- ICLR $125.10
- 52 Week High
- ALLY $45.46
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- ALLY 59.20
- ICLR 58.35
- Support Level
- ALLY $35.94
- ICLR $140.20
- Resistance Level
- ALLY $38.05
- ICLR $147.26
- Average True Range (ATR)
- ALLY 0.76
- ICLR 5.06
- MACD
- ALLY 0.03
- ICLR 1.39
- Stochastic Oscillator
- ALLY 70.53
- ICLR 85.25
About ALLY Ally Financial Inc.
Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending, with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.